The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $1,064,915 Formula Grant under the Protection and Advocacy for Individuals with Mental Illness (PAIMI) program (CFDA 93.138) to Disability Rights Arkansas Inc. The grant will fund the organization's efforts to protect and advocate for the legal and civil rights of individuals with mental illness in Arkansas over a two-year period from October 1, 2024 to September 30, 2026. Through this funding, Disability Rights...
This $1,121,145 federal Formula Grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Protection and Advocacy for Individuals with Mental Illness (PAIMI) program (CFDA 93.138) will enable Mid-Minnesota Legal Assistance, a non-profit organization, to provide comprehensive legal advocacy and support services to protect the rights of individuals with mental illness in Minnesota. The two-year grant, active from October 1, 2024 to September 30, 2026, will...
This $1,148,318.00 Formula Grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) Center for Mental Health Services supports the Protection and Advocacy for Individuals with Mental Illness (PAIMI) program. The grant will enable the University of Alabama's Office for Sponsored Programs to provide legal advocacy and support services protecting the civil and legal rights of individuals with mental illness across the state of Alabama. Key services delivered through...
This federal Formula Grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) provides $6,099,967.00 in funding for the Protection and Advocacy for Individuals with Mental Illness (PAIMI) program. The grant supports Disability Rights Texas, the designated Protection and Advocacy (P&A) system for the state of Texas, in delivering comprehensive legal advocacy and support services to protect the civil and legal rights of individuals with mental illness. Key...
The federal Formula Grant award of $1,327,296.00 was provided by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Protection and Advocacy for Individuals with Mental Illness (PAIMI) program (CFDA 93.138). The grant supports the Missouri Protection And Advocacy Services, a non-profit organization designated as the Protection and Advocacy (P&A) system for the state of Missouri, in delivering comprehensive legal advocacy, rights protection, and support services...
The Substance Abuse and Mental Health Services Administration (SAMHSA) has awarded a $2,584,836 Formula Grant under the Protection and Advocacy for Individuals with Mental Illness (PAIMI) program (CFDA 93.138) to Disability Rights Pennsylvania. This two-year grant, effective from October 1, 2024 to September 30, 2026, will enable Disability Rights Pennsylvania to provide comprehensive legal advocacy, investigative, and support services to protect and advance the civil and legal rights of...
The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $1,064,915 two-year Formula Grant under the Protection and Advocacy for Individuals with Mental Illness (PAIMI) program (CFDA 93.138) to the Disability Rights Center - NH Inc. in Concord, New Hampshire. This grant supports the organization's efforts to protect and advocate for the legal and civil rights of individuals with mental illness in the state. The funding enables the Disability Rights Center - NH to...
The U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $1,064,915 Formula Grant under the Protection and Advocacy for Individuals with Mental Illness (PAIMI) program (CFDA 93.138) to the Kentucky Department of Public Advocacy's Protection and Advocacy Division. This two-year grant, effective from October 1, 2024 to September 30, 2026, enables the organization to provide comprehensive legal advocacy, rights protection, and...
The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $1,698,111 Formula Grant under the Protection and Advocacy for Individuals with Mental Illness (PAIMI) program (CFDA 93.138) to Disability Rights New Jersey. This two-year grant, effective from October 1, 2024 to September 30, 2026, enables Disability Rights New Jersey, the designated Protection and Advocacy (P&A) organization for the state, to provide comprehensive legal advocacy, investigate incidents of abuse...
This $1,064,915 federal Formula Grant award, made by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Protection and Advocacy for Individuals with Mental Illness (PAIMI) program (CFDA 93.138), supports Disability Rights Montana, a non-profit civil rights organization, in providing legal advocacy, rights protection, and comprehensive support services for individuals with mental illness across the state of Montana. The grant funding enables Disability Rights Montana...